In this study, to further confirm our previous findings that reduced synaptic proteins in EVs are associated with the development of AD, we examined the relationship between concentrations of SNAP25, GAP43, neurogranin, and synaptotagmin 1 and degrees of hippocampal atrophy in patients with AD. Here, NRGN is linked to Alzheimer disease.